Back to results
US 11,306,104 B2Granted
Solid state forms of Relugolix
AssigneeTeva Pharmaceuticals International GmbH
InventorsHana Kantor, Roman Gabriel, Pavel Kolesa, Alexandr Jegorov
Life of this patent
Estimating the term…
Abstract
The present disclosure provides solid state forms of Relugolix, crystalline forms of Relugolix, pharmaceutical compositions thereof, and pharmaceutical formulations thereof. Methods for producing these forms of Relugolix, pharmaceutical compositions, and pharmaceutical formulations are also provided.
Claims12
Crystalline Form F of Relugolix, characterized by data selected from one or more of the following:
- a) an X-ray powder diffraction pattern substantially as depicted in FIG. 1 or in FIG. 7;
- b) an X-ray powder diffraction pattern having peaks at 6.9, 7.5, 9.5, 13.9 and 18.1 degrees 2-theta±0.2 degrees 2-theta;
- c) an FT-IR spectrum having peaks at 1720, 1680, 1626, 1595, 1528, 1460, 1412, 1313, 1237 and 1095 cm−1±4 cm−1;
- d) an FT-IR spectrum as depicted in FIG. 6a and/or 6b;
- and
- e) combinations of these data.
3 more elements
Dependencies are inferred from the claim text.